- JP-listed companies
- MEDINET Co., Ltd.
- Financials
- Net income margin (%)
MEDINET Co., Ltd. (2370)
Market cap
¥7.9B
P/E ratio
-5.5x
Medinet develops cell processing and regenerative medicine products for hospitals and pharmaceutical companies, offering manufacturing services and facility operations.
| Period End | Net income margin (%) | YoY (%) |
|---|---|---|
| Sep 30, 2025 | -168.1 | +1.17% |
| Sep 30, 2024 | -166.2 | -23.55% |
| Sep 30, 2023 | -217.4 | +9.83% |
| Sep 30, 2022 | -197.9 | +60.28% |
| Sep 30, 2021 | -123.5 | +14.83% |
| Sep 30, 2020 | -107.5 | +43.19% |
| Sep 30, 2019 | -75.1 | -75.41% |
| Sep 30, 2018 | -305.4 | +99.86% |
| Sep 30, 2017 | -152.8 | +77.54% |
| Sep 30, 2016 | -86.1 | -15.85% |
| Sep 30, 2015 | -102.3 | +19.30% |
| Sep 30, 2014 | -85.7 | +419.24% |
| Sep 30, 2013 | -16.5 | -42.12% |
| Sep 30, 2012 | -28.5 | +40.61% |
| Sep 30, 2011 | -20.3 |